BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6267931)

  • 1. Specific binding proteins for human chorionic gonadotrophin in a patient with trophoblastic disease.
    Chan DW; Bill MJ; Rosenshein N
    Am J Clin Pathol; 1981 Aug; 76(2):214-6. PubMed ID: 6267931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies against human chorionic gonadotropin following trophoblastic disease.
    de Bruijn HW; Groenhuis A; Aalders JG
    Gynecol Oncol; 1984 Sep; 19(1):114-9. PubMed ID: 6088369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of a rapid assay for human chorionic gonadotropin in the management of trophoblastic disease.
    Soules MR; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1979 Oct; 135(3):384-92. PubMed ID: 225953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved monitoring of gestational trophoblastic neoplasia using a highly sensitive assay for urinary human chorionic gonadotropin.
    Wehmann RE; Ayala AR; Birken S; Canfield RE; Nisula BC
    Am J Obstet Gynecol; 1981 Aug; 140(7):753-7. PubMed ID: 6266253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
    Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
    Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia.
    Wu T; Ballon SC; Teng NN
    Am J Obstet Gynecol; 1983 Dec; 147(7):821-5. PubMed ID: 6196974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of beta-subunit chorionic gonadotropin as an aid in diagnosis of trophoblastic disease.
    Skinner MS; Seckinger D
    Ann Clin Lab Sci; 1979; 9(4):347-52. PubMed ID: 225983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific enzyme immunoassay for human chorionic gonadotrophin.
    Sekiya T; Furuhashi Y; Goto S; Kaseki S; Tomoda Y; Kato K
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):562-8. PubMed ID: 6267861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
    Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
    Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding sites for epidermal growth factor and its effect on human chorionic gonadotrophin secretion by cultured tumour cell lines: comparison between trophoblastic and non-trophoblastic cells.
    Hirata Y; Sueoka S; Uchihashi M; Yoshimoto Y; Fujita T; Matsukura S; Motoyama T
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):281-6. PubMed ID: 6291299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trophoblastic disease monitoring.
    O'Brien TJ
    Clin Obstet Gynecol; 1984 Mar; 27(1):240-7. PubMed ID: 6200261
    [No Abstract]   [Full Text] [Related]  

  • 19. Non trophoblastic source of human chorionic gonadotropin - problem in diagnostic accuracy.
    Dabrowski F; Grzechocinska B; Cyganek A; Wielgos M
    Neuro Endocrinol Lett; 2015; 36(4):316-9. PubMed ID: 26454486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.